Kardium
Burnaby · Founded 2013 · Canada (Federal Level) corporation · 5 known investors
Kardium develops the Globe Pulsed Field System, an all-in-one cardiac ablation catheter with 122 individually selectable electrodes that combines high-density mapping and pulsed field ablation. It is designed for physicians treating patients with atrial fibrillation.
Founders & leadership
DG

Doug GoertzenExecutive
KC

Kevin ChaplinExecutive
AM
Armos MichelsonNamed on SEC filing
Board
MA
Manuel Alba-MarquezBoard director
II
Ian IhnatowyczBoard director
DR
David RosaBoard director
Investors · 5
Reported raises · per SEC filings
Form D private placements$116.6M disclosed across 2 of 3 rounds · 2014–2025
▶$116.3MraisedApr 2021 · 29 investors · Other Health CareRule 506(b)
▶$116.3MraisedApr 2021 · 29 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Manuel Alba-MarquezDirector
- Ian IhnatowyczDirector
- David RosaDirector
- Doug GoertzenExecutive Officer
- Kevin ChaplinExecutive Officer, Director
- Offering amount
- $116.3M
- Amount sold
- $116.3M
- Minimum investment
- $1
- First sale
- Dec 2020
- Incorporated
- Corporation, Canada (federal Level)
- Federal exemptions
- 06b
▶$269.2KraisedApr 2014 · 2 investors · BiotechnologyRule 506(b)
▶$269.2KraisedApr 2014 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Armos MichelsonDirector
- Manuel Alba-MarquezDirector
- Doug GoertzenExecutive Officer, Director
- Offering amount
- $269.2K
- Amount sold
- $269.2K
- First sale
- Mar 2014
- Incorporated
- Corporation, Canada (federal Level), 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapRf Surgical19 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Boston Scientific10 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Bioworld10 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies competing with Kardium for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Kardium do?
- Kardium develops the Globe Pulsed Field System, an all-in-one cardiac ablation catheter with 122 individually selectable electrodes that combines high-density mapping and pulsed field ablation. It is designed for physicians treating patients with atrial fibrillation.
- Who are Kardium's investors?
- Kardium's investors include Granada Funds, Eckuity, Fidelity Investments, Janus Henderson Investors, Qatar Investment Authority.
- How much funding has Kardium raised?
- Kardium has disclosed $116.6M raised across 2 of its 3 known rounds.
- Where is Kardium headquartered?
- Kardium is headquartered in Burnaby.
